Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorEl‐Feky, Yasmin A.
dc.contributor.authorMostafa, Dalia A.
dc.contributor.authorAl-Sawahli, Majid M.
dc.contributor.authorEl‐Telbany, Rania Farag A.
dc.contributor.authorZakaria, Sherin
dc.contributor.authorFayez, Ahmed M.
dc.contributor.authorAhmed, Kawkab A.
dc.contributor.authorEbtesam M Alolayan
dc.contributor.authorDalia Farag A El-Telbany
dc.date.accessioned2020-03-18T10:11:22Z
dc.date.available2020-03-18T10:11:22Z
dc.date.issued2020-05-01
dc.descriptionSJR 2024 0.717 Q2 H-Index 142
dc.description.abstractObjective: To enhance bioavailability of timolol (TML) and utilize alternatives for traditional eye drops for more patient compliance, this study was aiming to develop biodegradable orally dissolving strips (ODSs) of TML for treatment of primary open-angle glaucoma (POAG). Methods: Novel ODSs of TML were formulated and optimized using solvent casting method according to full factorial design (31.22). TML ODSs were characterized with respect to many parameters. In-vivo test was carried out using four groups of 24 New Zealand albino rabbits. POAG was induced by subconjunctival treatment of betamethasone. Histopathological examination and oxidative stress markers assay were carried out. Key findings: The optimized formula (F9) exhibited a remarkably 15-s disintegration time and 96% dissolution rate after 10 min. The results revealed a potent significant inhibitory effect of the optimized TML ODS to reduce IOP in induced rabbits in comparison with control rabbits and TML eye drops-treated rabbits. The formula showed also high activity against oxidative stress and absence of histopathological changes in iridocorneal angle and cornea. Conclusion: The ODSs could be a promising alternative delivery system for eye drops with more compliance to enhance delivery and therapeutic activity of TML in treatment of POAG.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=23102&tip=sid&clean=0
dc.identifier.citationEl-Feky, Y. A., Mostafa, D. A., Al-Sawahli, M. M., El-Telbany, R. F. A., Zakaria, S., Fayez, A. M., Ahmed, K. A., Alolayan, E. M., & El-Telbany, D. F. A. (2020). Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits. Journal of Pharmacy and Pharmacology, 72(5), 682–698. https://doi.org/10.1111/jphp.13239 ‌
dc.identifier.doihttps://doi.org/10.1111/jphp.13239
dc.identifier.otherhttps://doi.org/10.1111/jphp.13239
dc.identifier.urihttps://t.ly/nr5Bn
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofseriesJournal of Pharmacy and Pharmacology,;Volume 72, Issue 5, May 2020, Pages 682–698
dc.subjectuniversity of timololen_US
dc.subjectprimary open-angle glaucomaen_US
dc.subjectorally dissolving stripsen_US
dc.subjectfast releaseen_US
dc.subjectintraocular pressureen_US
dc.titleReduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbitsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: